BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30954980)

  • 1. Maintenance treatment with trofosfamide in patients with primary bone ewing sarcoma - single center experience.
    Raciborska A; Bilska K; Rodriguez-Galindo C
    Dev Period Med; 2019; 23(1):39-44. PubMed ID: 30954980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral trofosfamide: an active and well-tolerated maintenance therapy for adult patients with advanced bone and soft tissue sarcomas. Results of a retrospective analysis.
    Reichardt P; Pink D; Tilgner J; Kretzschmar A; Thuss-Patience PC; Dörken B
    Onkologie; 2002 Dec; 25(6):541-6. PubMed ID: 12566899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas.
    Hartmann JT; Oechsle K; Mayer F; Kanz L; Bokemeyer C
    Anticancer Res; 2003; 23(2C):1899-901. PubMed ID: 12820475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.
    Womer RB; West DC; Krailo MD; Dickman PS; Pawel BR; Grier HE; Marcus K; Sailer S; Healey JH; Dormans JP; Weiss AR
    J Clin Oncol; 2012 Nov; 30(33):4148-54. PubMed ID: 23091096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy in patients with refractory Ewing sarcoma].
    Raciborska A; Bilska K; Drabko K; Rogowska E; Chaber R; Pogorzała M; Wyrobek E; Połczyńska K; Rodriguez-Galindo C; Woźniak W
    Med Wieku Rozwoj; 2013; 17(2):117-25. PubMed ID: 23988368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide and topotecan as first-line salvage therapy in patients with relapsed ewing sarcoma at a single institution.
    Farhat R; Raad R; Khoury NJ; Feghaly J; Eid T; Muwakkit S; Abboud M; El-Solh H; Saab R
    J Pediatr Hematol Oncol; 2013 Jul; 35(5):356-60. PubMed ID: 23042020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VIP (etoposide, ifosfamide, cisplatin) in adult patients with recurrent or refractory Ewing sarcoma family of tumors.
    El Weshi A; Memon M; Raja M; Bazarbashi S; Rahal M; El Foudeh M; Pai C; Allam A; El Hassan I; Ezzat A
    Am J Clin Oncol; 2004 Oct; 27(5):529-34. PubMed ID: 15596925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group.
    Baruchel S; Pappo A; Krailo M; Baker KS; Wu B; Villaluna D; Lee-Scott M; Adamson PC; Blaney SM
    Eur J Cancer; 2012 Mar; 48(4):579-85. PubMed ID: 22088484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy Regimen.
    Vijayasekharan K; Ramanathan S; Chinnaswamy G; Prasad M; Gulia A; Janu A; Rekhi B; Ramadwar M; Khanna N; Laskar S; Puranadare N; Bajpai J; Puri A; Banavali S; Vora T
    J Adolesc Young Adult Oncol; 2021 Apr; 10(2):185-192. PubMed ID: 32706630
    [No Abstract]   [Full Text] [Related]  

  • 10. A modified protocol with vincristine, topotecan, and cyclophosphamide for recurrent/progressive ewing sarcoma family tumors.
    Kebudi R; Cakir FB; Gorgun O; Agaoglu FY; Darendeliler E
    Pediatr Hematol Oncol; 2013 Apr; 30(3):170-7. PubMed ID: 23484903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma.
    Witte HM; Riecke A; Mayer T; Bartscht T; Rades D; Lehnert H; Merz H; Fetscher S; Biersack H; Gebauer N
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):129-136. PubMed ID: 30327940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous Ewing sarcoma presenting as a chest wall lesion.
    Xu JH; Abeysinghe V; Ryan AL; Sieunarine K
    BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28954747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone.
    Meyer WH; Kun L; Marina N; Roberson P; Parham D; Rao B; Fletcher B; Pratt CB
    J Clin Oncol; 1992 Nov; 10(11):1737-42. PubMed ID: 1403056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of Treating Adults with Ewing or Ewing-Like Sarcoma with Interval-Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and Etoposide.
    Lu E; Ryan CW; Bassale S; Lim JY; Davis LE
    Oncologist; 2020 Feb; 25(2):150-155. PubMed ID: 32043790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stabilizing the course of patients with stage IV advanced malignant melanoma by trofosfamide treatment].
    Enk AH; Knop J
    Hautarzt; 2000 Jul; 51(7):486-9. PubMed ID: 10969402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide.
    Kroiss M; Deutschbein T; Schlötelburg W; Ronchi CL; Neu B; Müller HH; Quinkler M; Hahner S; Heidemeier A; Fassnacht M;
    Horm Cancer; 2016 Jun; 7(3):211-8. PubMed ID: 26961793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma.
    Kollmannsberger C; Brugger W; Hartmann JT; Maurer F; Böhm P; Kanz L; Bokemeyer C
    Anticancer Drugs; 1999 Jun; 10(5):453-6. PubMed ID: 10477164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma.
    Raciborska A; Bilska K; Drabko K; Chaber R; Pogorzala M; Wyrobek E; Polczyńska K; Rogowska E; Rodriguez-Galindo C; Wozniak W
    Pediatr Blood Cancer; 2013 Oct; 60(10):1621-5. PubMed ID: 23776128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose escalation study for defining the maximum tolerated dose of continuous oral trofosfamide in pretreated patients with metastatic lung cancer.
    Al-Batran SE; Atmaca A; Bert F; Jäger D; Frisch C; Neumann A; Orth J; Knuth A; Jäger E
    Onkologie; 2004 Dec; 27(6):534-8. PubMed ID: 15591711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Ewing Family of Tumors of the Jaw Has a Better Prognosis Compared to Tumors of Extragnathic Sites.
    Owosho AA; Ko E; Rosenberg HI; Yom SK; Antonescu CR; Huryn JM; Estilo CL
    J Oral Maxillofac Surg; 2016 May; 74(5):973-81. PubMed ID: 26679553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.